The autoimmune protocol, AIP, has become one of the most popular diet interventions for autoimmune conditions on the wellness internet. It has helped some patients meaningfully. It has also produced a culture of dietary anxiety that does its own harm. The honest version is that AIP contains useful principles wrapped in unnecessary restriction, and that for Indian patients specifically, it needs adapting before it produces consistent benefit. This is the careful read on what works, what does not, and how to use the useful parts.
What AIP actually is
The Autoimmune Protocol is a structured elimination diet developed in the 2010s, primarily through the work of Sarah Ballantyne. The premise is that autoimmune disease is partly driven by gut-mediated immune activation, and that removing the dietary triggers most likely to cross-react with autoimmune tissue can reduce disease activity.
The standard AIP eliminates a long list of foods: grains, legumes, dairy, eggs, nuts, seeds, nightshades (tomatoes, peppers, eggplant, potatoes), alcohol, coffee, refined sugars, processed foods, and most oils except coconut, olive, avocado, and some animal fats. Foods are eliminated for 30-90 days, then reintroduced systematically while monitoring for symptom flares.
The theoretical basis is reasonable: identify the foods most likely to be triggering immune activation and remove them, then reintroduce to test causation. The clinical reality is more complicated.
What the evidence says
The published evidence on AIP is limited but growing. The strongest data comes from small trials in Hashimoto's, IBD, and a few other conditions.
Hashimoto's. A 2019 pilot study showed AIP reduced thyroid antibody levels and improved symptoms in a small cohort over ten weeks. The effect was meaningful but the trial was uncontrolled and small.
IBD (Crohn's and ulcerative colitis). A 2017 study showed AIP induced clinical remission in 73% of patients in an 11-week intervention. Mucosal healing was confirmed in some patients. This is the strongest dataset for AIP.
Other autoimmune conditions. The data is anecdotal or inferential. Many patients with lupus, rheumatoid arthritis, MS, and other conditions report improvement on AIP, but the formal trials are limited.
The honest summary is that AIP has reasonable evidence in IBD, modest evidence in Hashimoto's, and inferential evidence elsewhere. It is not snake oil. It is also not a universal autoimmune cure.
What works in AIP
Several principles within AIP have evidence and are worth keeping in any autoimmune protocol.
Reducing ultra-processed food. Industrial seed oils, refined sugars, processed grains, and ultra-processed meats are inflammatory. Cutting them down helps almost everyone with autoimmune disease.
Identifying gluten reactivity in genetic carriers. Patients with HLA-DQ2 or DQ8 and active autoimmune disease often respond to gluten removal. This is a subset of patients, not all of them, but the response in the right patient is real.
Identifying dairy reactivity in some patients. Some autoimmune patients have a genuine cross-reactivity story with dairy proteins. A 4-6 week trial elimination, followed by reintroduction, identifies this clearly.
Increasing nutrient density. AIP emphasises vegetables, organ meats (in some versions), bone broth, and fermented foods. The general direction is nutrient-dense whole-food eating, which supports gut and immune function.
Eliminating alcohol. Alcohol is genuinely problematic for autoimmune patients. AIP is right to remove it.
Identifying nightshade reactivity in a small subset. Some patients with rheumatological conditions report improvement when nightshades are eliminated. The mechanism is unclear and the responder rate is small, but for the patients who respond, it is meaningful.
These principles can be adopted without doing the full AIP elimination.
The principles inside AIP are useful. The full elimination is unnecessary for most patients.
What AIP overdoes
Several aspects of AIP are excessive for most patients and produce more harm than benefit.
Eliminating eggs by default. Eggs are one of the most nutritionally dense and bioavailable protein sources available. The evidence that they trigger autoimmunity in most patients is weak. Removing them by default produces unnecessary nutrient gaps, especially in already-restrictive diets.
Eliminating all nuts and seeds. Almonds, walnuts, pumpkin seeds, sunflower seeds, and chia are useful sources of protein, magnesium, omega-3, and zinc. The evidence that they trigger autoimmunity is weak. Removing them complicates Indian eating patterns substantially.
Eliminating all legumes. Dal, chickpeas, beans, and lentils are central to Indian eating. The lectin-driven theoretical concerns about legumes have weak evidence in autoimmune disease. Removing them produces both protein gaps and cultural disruption that is often unsustainable.
Eliminating all grains. Even non-gluten grains like rice and millet are removed in standard AIP. The evidence base for this is thin outside of celiac disease and active gluten sensitivity.
The duration. Standard AIP is 30-90 days of full elimination. For Indian patients eating predominantly vegetarian, this often produces meaningful nutrient deficiencies (especially B12, iron, zinc, calcium) and disordered eating patterns that outlast the protocol.
The reintroduction structure. Many patients never actually complete the structured reintroduction. They get stuck in the elimination phase for months or years, becoming progressively more restricted and more anxious about food.
How we adapt it for Indian patients
In our clinic, the practical version of AIP for autoimmune patients looks more like this.
Phase 1, four weeks: targeted elimination. Remove the foods most likely to be driving the picture for this patient. Usually gluten (in genetic carriers or those with active autoimmune signs) and dairy. Sometimes alcohol and ultra-processed foods if they are still in the picture. We rarely eliminate eggs, nuts, seeds, legumes, or non-gluten grains in this phase.
Phase 2, four weeks: gut work. Whatever the gut needs based on the comprehensive stool analysis. Often SIBO treatment, dysbiosis correction, or barrier support. The diet stays steady through this phase.
Phase 3, four weeks: structured reintroduction. If we eliminated gluten and dairy in phase 1, we reintroduce them one at a time over four weeks while watching for symptom return. About half of patients have a clear response to one or both. About half do not, and reincorporate them.
Phase 4, ongoing: nutrient-dense maintenance. Whole-food, anti-inflammatory eating that fits the patient's life. Most patients end up with a diet that includes most foods, prepared in less inflammatory ways.
This adapted version captures the clinical benefit of AIP without the unnecessary restriction or the cultural disruption.
The patients who do better with full AIP
Some patients genuinely benefit from a more complete elimination protocol, at least for a defined period.
Active IBD with significant disease activity. The IBD evidence supports a stricter approach during active disease.
Hashimoto's with very high antibodies and limited response to standard interventions. A 60-day strict trial sometimes produces meaningful antibody reduction.
Patients with multiple food sensitivities and a clear pattern of progressive food intolerance. The full reset can be useful, with structured reintroduction.
Patients with multiple autoimmune conditions and significant clinical instability. A more aggressive intervention can be justified.
For these patients, we use a closer-to-full AIP for a defined window (8-12 weeks), then reintroduce systematically.
What we are not doing
We are not selling 12-week AIP programmes. The intervention belongs to the patient, not the clinic.
We are not asking patients to stay on AIP indefinitely. The goal is the structured reintroduction, not lifelong restriction.
We are not pretending AIP is a substitute for specialist care. Methotrexate, hydroxychloroquine, biologics, and other immunosuppressants stay in the picture under specialist supervision. We work alongside, not against.
The autoimmune pillar guide is the broader read on autoimmune disease management.
